These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

826 related items for PubMed ID: 26428157

  • 1. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
    Devasari N, Dora CP, Singh C, Paidi SR, Kumar V, Sobhia ME, Suresh S.
    Carbohydr Polym; 2015 Dec 10; 134():547-56. PubMed ID: 26428157
    [Abstract] [Full Text] [Related]

  • 2. Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability.
    Dora CP, Trotta F, Kushwah V, Devasari N, Singh C, Suresh S, Jain S.
    Carbohydr Polym; 2016 Feb 10; 137():339-349. PubMed ID: 26686138
    [Abstract] [Full Text] [Related]

  • 3. Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid.
    Dora CP, Kushwah V, Katiyar SS, Kumar P, Pillay V, Suresh S, Jain S.
    Int J Pharm; 2017 Dec 20; 534(1-2):1-13. PubMed ID: 28970115
    [Abstract] [Full Text] [Related]

  • 4. Erlotinib complexation with randomly methylated β-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer.
    Erdoğar N, Akkın S, Varan G, Bilensoy E.
    Pharm Dev Technol; 2021 Sep 20; 26(7):797-806. PubMed ID: 34219578
    [Abstract] [Full Text] [Related]

  • 5. Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity.
    Jain AS, Date AA, Pissurlenkar RR, Coutinho EC, Nagarsenker MS.
    AAPS PharmSciTech; 2011 Dec 20; 12(4):1163-75. PubMed ID: 21918921
    [Abstract] [Full Text] [Related]

  • 6. Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity.
    Tang P, Li S, Wang L, Yang H, Yan J, Li H.
    Carbohydr Polym; 2015 Oct 20; 131():297-305. PubMed ID: 26256188
    [Abstract] [Full Text] [Related]

  • 7. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov 20; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 8. Characterization and evaluation of synthetic riluzole with β-cyclodextrin and 2,6-di-O-methyl-β-cyclodextrin inclusion complexes.
    Wang L, Li S, Tang P, Yan J, Xu K, Li H.
    Carbohydr Polym; 2015 Sep 20; 129():9-16. PubMed ID: 26050882
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Posaconazole/hydroxypropyl-β-cyclodextrin host-guest system: Improving dissolution while maintaining antifungal activity.
    Tang P, Ma X, Wu D, Li S, Xu K, Tang B, Li H.
    Carbohydr Polym; 2016 May 20; 142():16-23. PubMed ID: 26917368
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
    Liu J, Qiu L, Gao J, Jin Y.
    Int J Pharm; 2006 Apr 07; 312(1-2):137-43. PubMed ID: 16459034
    [Abstract] [Full Text] [Related]

  • 13. Investigation of inclusion complex of honokiol with sulfobutyl ether-β-cyclodextrin.
    Xu C, Tang Y, Hu W, Tian R, Jia Y, Deng P, Zhang L.
    Carbohydr Polym; 2014 Nov 26; 113():9-15. PubMed ID: 25256452
    [Abstract] [Full Text] [Related]

  • 14. Preparation, characteristic and pharmacological study on inclusion complex of sulfobutylether-β-cyclodextrin with glaucocalyxin A.
    Ren L, Jing J, Chen G, Miao Y, Wei P.
    J Pharm Pharmacol; 2014 Jul 26; 66(7):927-34. PubMed ID: 24697809
    [Abstract] [Full Text] [Related]

  • 15. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
    Chauhan R, Madan J, Kaushik D, Sardana S, Pandey RS, Sharma R.
    Pharm Dev Technol; 2013 Jul 26; 18(2):313-22. PubMed ID: 21699389
    [Abstract] [Full Text] [Related]

  • 16. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J, Dhiman N, Parmar VK, Sardana S, Bharatam PV, Aneja R, Chandra R, Katyal A.
    Cancer Chemother Pharmacol; 2010 Feb 26; 65(3):537-48. PubMed ID: 19597818
    [Abstract] [Full Text] [Related]

  • 17. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
    Lee PS, Han JY, Song TW, Sung JH, Kwon OS, Song S, Chung YB.
    Int J Pharm; 2006 Jun 19; 316(1-2):29-36. PubMed ID: 16574357
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ.
    Eur J Pharm Biopharm; 2007 Jun 19; 66(3):413-21. PubMed ID: 17240129
    [Abstract] [Full Text] [Related]

  • 20. Development of a myricetin/hydroxypropyl-β-cyclodextrin inclusion complex: preparation, characterization, and evaluation.
    Yao Y, Xie Y, Hong C, Li G, Shen H, Ji G.
    Carbohydr Polym; 2014 Sep 22; 110():329-37. PubMed ID: 24906763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.